Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

15.50
Delayed Data
As of Aug 28
 -0.26 / -1.65%
Today’s Change
11.18
Today|||52-Week Range
30.23
-37.45%
Year-to-Date

Today’s Trading

Previous close15.76
Today’s open15.57
Day’s range14.92 - 15.89
Volume967,759
Average volume (3 months)1,212,572
Market cap$587.2M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-59.71%
Earnings growth (this year)+17.57%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)-66.31%
P/E ratioNM
Price/Sales1,527.91
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CHMAChiasma Inc-0.50-1.93%
OTICOtonomy Inc+0.12+0.51%
AMPHAmphastar Pharmaceut...-0.42-3.04%
OMEDOncoMed Pharmaceutic...+0.66+3.35%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$539.0K
Annual profit (last year)-$73.7M
Net profit margin-13,668.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers